Skip to main content
Drug bottle and Pill

Compare Epclusa vs. Zepatier

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Epclusa (sofosbuvir/velpatasvir) and Zepatier (elbasvir/grazoprevir) are both antiviral medications used to treat hepatitis C, but they have some key differences. Epclusa treats all six types of hepatitis C, while Zepatier is only effective for genotypes 1 and 4. Epclusa can be used in both adults and children aged 3 and older, whereas Zepatier is primarily for those ages 12 and older. Zepatier is a good option for people with kidney problems, including those on hemodialysis, and it doesn't interact with stomach acid medications, unlike Epclusa. However, Zepatier cannot be used in people with cirrhosis or moderate to severe liver problems, and it requires resistance testing for hepatitis C type 1 before starting therapy. Both medications have similar common side effects like headache and fatigue, but Epclusa has additional risks such as slow heart rate when taken with amiodarone and potential reactivation of hepatitis B.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.